Payment overview · 2025
General Payments
$30.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Vercin S Ephrem, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LACONIA, NH · NPI 1366468928
Verified facts
What the public records show
CMS Open Payments records show Vercin S Ephrem, MD received $30.00 in general payments during 2025 across 1 reported records.
Becton, Dickinson and Company accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $30.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PowerPICC Normalized: powerpicc |
Device | Becton, Dickinson and Company | $30.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 666 | 100 |
| Atorvastatin Calcium | Atorvastatin Calcium | 594 | 111 |
| Levothyroxine Sodium | Levothyroxine Sodium | 549 | 68 |
| Amlodipine Besylate | Amlodipine Besylate | 453 | 77 |
| Eliquis | Apixaban | 376 | 57 |
| Gabapentin | Gabapentin | 363 | 74 |
| Metoprolol Tartrate | Metoprolol Tartrate | 321 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 299 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 276 | 68 |
| Trazodone Hcl | Trazodone Hcl | 246 | 43 |
| Losartan Potassium | Losartan Potassium | 227 | 41 |
| Potassium Chloride | Potassium Chloride | 193 | 52 |
| Sertraline Hcl | Sertraline Hcl | 187 | 33 |
| Glipizide | Glipizide | 185 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 179 | 27 |
| Tamsulosin Hcl | Tamsulosin Hcl | 179 | 41 |
| Donepezil Hcl | Donepezil Hcl | 165 | 21 |
| Warfarin Sodium | Warfarin Sodium | 165 | 15 |
| Lisinopril | Lisinopril | 162 | 39 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 141 | 66 |
| Duloxetine Hcl | Duloxetine Hcl | 139 | 24 |
| Simvastatin | Simvastatin | 125 | 17 |
| Omeprazole | Omeprazole | 118 | 19 |
| Baclofen | Baclofen | 116 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 113 | 24 |
| Metformin Hcl | Metformin Hcl | 112 | 22 |
| Cephalexin | Cephalexin | 111 | 60 |
| Levetiracetam | Levetiracetam | 109 | 20 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 101 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 101 | 38 |
| Prednisone | Prednisone | 100 | 55 |
| Myrbetriq | Mirabegron | 96 | suppressed |
| Mirtazapine | Mirtazapine | 90 | 25 |
| Memantine Hcl | Memantine Hcl | 89 | 16 |
| Spironolactone | Spironolactone | 87 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 84 | 16 |
| Finasteride | Finasteride | 78 | 16 |
| Carvedilol | Carvedilol | 76 | 15 |
| Famotidine | Famotidine | 75 | 18 |
| Divalproex Sodium | Divalproex Sodium | 73 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 70 | 19 |
| Jardiance | Empagliflozin | 69 | 11 |
| Allopurinol | Allopurinol | 66 | 14 |
| Latanoprost | Latanoprost | 66 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 61 | suppressed |
| Olanzapine | Olanzapine | 61 | suppressed |
| Ssd | Silver Sulfadiazine | 58 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 56 | 20 |
| Trulicity | Dulaglutide | 56 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 54 | 30 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 54 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | suppressed |
| Jantoven | Warfarin Sodium | 49 | suppressed |
| Lamotrigine | Lamotrigine | 48 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 46 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | suppressed |
| Humalog | Insulin Lispro | 43 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 43 | 15 |
| Clotrimazole | Clotrimazole | 42 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 42 | 20 |
| Brilinta | Ticagrelor | 41 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 41 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 39 | suppressed |
| Ezetimibe | Ezetimibe | 38 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 38 | 20 |
| Torsemide | Torsemide | 38 | 14 |
| Clonidine Hcl | Clonidine Hcl | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 35 | suppressed |
| Atenolol | Atenolol | 34 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 34 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 34 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Zonisamide | Zonisamide | 34 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 32 | suppressed |
| Lansoprazole | Lansoprazole | 32 | suppressed |
| Ondansetron Odt | Ondansetron | 32 | 18 |
| Digoxin | Digoxin | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 21 |
| Albuterol Sulfate | Albuterol Sulfate | 29 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | 13 |
| Ozempic | Semaglutide | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 17 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 27 | suppressed |
| Lorazepam | Lorazepam | 27 | 17 |
| Paxlovid | Nirmatrelvir/Ritonavir | 27 | 27 |
| Tizanidine Hcl | Tizanidine Hcl | 27 | suppressed |
| Amantadine | Amantadine Hcl | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 26 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 26 | 16 |
| Oxcarbazepine | Oxcarbazepine | 26 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 26 | 15 |
| Sodium Chloride | 0.9 % Sodium Chloride | 26 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 25 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 25 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 24 | 20 |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Konvomep | Omeprazole/Sodium Bicarbonate | 24 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Acetic Acid | Acetic Acid | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | suppressed |
| Klor-Con 10 | Potassium Chloride | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Mirabegron Er | Mirabegron | 22 | suppressed |
| Phenytoin | Phenytoin | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 21 | 14 |
| Erythromycin | Erythromycin Base | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Meloxicam | Meloxicam | 21 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Vraylar | Cariprazine Hcl | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 19 | suppressed |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Paricalcitol | Paricalcitol | 19 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | suppressed |
| Nystatin | Nystatin | 18 | 13 |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Clozapine | Clozapine | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 15 | suppressed |
| Travoprost | Travoprost | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | 11 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | 13 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 13 | 12 |
| Enulose | Lactulose | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Calcipotriene | Calcipotriene | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 12 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Alprazolam | Alprazolam | 11 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Hydroxyurea | Hydroxyurea | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $30.00 · 1 records | Becton, Dickinson and Company | PowerPICC | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error